Safety and Efficacy of Intrathecal NTF001 Injection in ALS

Clinical trial NCT07618585 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07618585
Sponsor: Ruijin Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

ALS - Amyotrophic Lateral Sclerosis ALS (Amyotrophic Lateral Sclerosis)

Start date: 2026-04-01
Primary completion: 2028-03-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.